Form 4: HealthEquity Executive Sells Shares in Recent Transaction

Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, Inc., sold 2,869 shares of common stock at a price of $97.1193 per share on December 12, 2024.

Summary

• Elimelech Rosner, the EVP and Chief Technology Officer of HealthEquity, Inc., executed a sale of company stock.
• The transaction involved the sale of 2,869 shares of common stock.
• The sale price was $97.1193 per share.
• The transaction took place on December 12, 2024.
• Following the transaction, Mr. Rosner directly owns 57,195 shares of HealthEquity stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by an executive, which is a routine event and does not indicate any positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence and are often part of compensation packages or personal financial planning. This transaction is not unusual for a company of this size and stage.

Comparison to Industry Standards

• Executive stock sales are a normal part of corporate activity, and this transaction is consistent with typical practices.
• Similar transactions are regularly seen at comparable companies such as WageWorks (now part of HealthEquity) and Benefitfocus, where executives may sell shares for personal financial management.

Stakeholder Impact

• The stock sale may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small number of shares sold compared to the total outstanding shares.

Key Dates

Keywords

HealthEquity, stock sale, executive transaction, insider trading, HQY, Elimelech Rosner